CB2 cannabinoid receptor-specific therapeutic antibody agonists for treatment of chemotherapy-induced peripheral neuropathy
Carlos Henrique Alves Jesus, Gopireddy Raghavender Reddy, Emily Fender Sizemore, Jonah L. Wirt, Swastik Sen, Richard C. Yu, Toshihiko Takeuchi, Lauren J. Schwimmer, Andrea G. Hohmann
This study evaluates CB2-specific antibody agonists for treating chemotherapy-induced peripheral neuropathy, showing pain relief without tolerance or off-target effects.
bioRxiv · Nov 26, 2025 · PreprintNeuroscience